GlassScriptPhysician profile
Shoeb Khan
NPI 1558823872
$3,098.50
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.85 · 2021: $144 · 2022: $895 · 2023: $1,020 · 2024: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,341 · Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,340.51 |
| Food and Beverage | $701.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,021.89 | 2024 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Neuropace, INC. | $932.84 | 2023 | |
| Abbvie INC. | $340.55 | 2022-2023 | |
| Biogen, INC. | $299.04 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $154.45 | 2021-2022 | |
| Csl Behring | $90.19 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $84.51 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $60.93 | 2022 | |
| Medtronic, INC. | $40.10 | 2021-2023 | Axium Primetm |
| Emd Serono, INC. | $34.64 | 2023 | Mavenclad |
| Argenx US, INC. | $21.51 | 2023 | Vyvgart |
| Lilly USA, LLC | $17.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shoeb Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.